Cellosaurus PAX-C002 (CVCL_D7E6)
Cell line name | PAX-C002 | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms | PAXC002 | ||||||||||||||||||
Accession | CVCL_D7E6 | ||||||||||||||||||
Resource Identification Initiative | To cite this cell line use: PAX-C002 (RRID:CVCL_D7E6) | ||||||||||||||||||
Comments | Group: Patented cell line. Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201010. Population: Chinese. Characteristics: Established from a xenograft produced by subcutaneous injection of tumor cells into SCID mice (PubMed=22076649). Characteristics: Gemcitabine resistant (Patent=CN102329775B; PubMed=22076649). Doubling time: 47.65 hours (Patent=CN102329775B); ~48 hours (PubMed=22076649). Derived from site: In situ; Pancreas; UBERON=UBERON_0001264. | ||||||||||||||||||
Disease | Pancreatic ductal adenocarcinoma (NCIt: C9120) | ||||||||||||||||||
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) | ||||||||||||||||||
Sex of cell | Female | ||||||||||||||||||
Age at sampling | 56Y | ||||||||||||||||||
Category | Cancer cell line | ||||||||||||||||||
STR profile | Source(s): PubMed=22325559 Markers:
Run an STR similarity search on this cell line | ||||||||||||||||||
Publications | PubMed=22076649; DOI=10.3892/ijo.2011.1254 PubMed=22325559; DOI=10.1111/j.1742-4658.2012.08521.x Patent=CN102329775B | ||||||||||||||||||
Cross-references | |||||||||||||||||||
Cell line databases/resources | CCRID; 4201PAT-CCTCC00330 | ||||||||||||||||||
Experimental variables resources | EFO; EFO_0022552 | ||||||||||||||||||
Entry history | |||||||||||||||||||
Entry creation | 10-Sep-2024 | ||||||||||||||||||
Last entry update | 10-Sep-2024 | ||||||||||||||||||
Version number | 1 |